ProCE Banner Series

Improving Outcomes in Patients with Retinal Vein Occlusion (RVO): Tailoring Treatment

Hear from ophthalmology experts about anti-VEGF therapies for RVO, develop treatment protocols that use current therapies most effectively to improve outcomes, and individualized treatment protocols for patients who are nonresponsive to first-line therapies and who require chronic treatment for macular edema.

  AMA
Who Should Attend

The intended audience for this educational initiative is ophthalmologists, who are clinicians responsible for the ocular evaluation and management of patients with retinal vein occlusion.

All Events

Improving Outcomes in Patients with Retinal Vein Occlusion (RVO): Tailoring Treatment

Past Events

October

10

2023

6:40 PM - 7:40 PM Mountain Time (MT)

In-personVirtual

Maggianos, 7401 S. Clinton St., Englewood, Colorado 80112

October

17

2023

7:00 PM - 8:00 PM Central Time (CT)

Virtual

February

29

2024

6:30 PM - 7:30 PM Eastern Time (ET)

In-person

Harry’s Savoy and Grill, 2020 Naamans Road, Wilmington, Delaware 19810

Faculty

ProCE Banner Faculty
Sai Achi, MD, MBA

Nephrologist
Kidney Associates of North Houston
Kingwood, Texas

ProCE Banner Faculty
Zaaira Ahmad, MD

Managing Partner
Director of Clinical Research
Director of Medical Education
Retina Consultants of Delmarva
Salisbury, Maryland

ProCE Banner Faculty
Carl J. Danzig, MD

Director of Vitreoretinal Services and Retina Clinical Research
Rand Eye Institute
Deerfield Beach, Florida
Affiliate Assistant Professor of Clinical Biomedical Science
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, Florida

ProCE Banner Faculty
Avni Finn, MD, MBA

Assistant Professor of Ophthalmology
Vanderbilt Eye Institute
Nashville, Tennessee

ProCE Banner Faculty
Arshad M. Khanani, MD, MA, FASRS

Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada
Reno, Nevada

ProCE Banner Faculty
Ashleigh Levison, MD

Partner Physician
Colorado Retina Associates
Denver, Colorado 

Topics

  • Welcome and Introduction
  • Differences in Efficacy of Anti-VEGF Therapies in RVO
  • Preventing Undertreatment by Tailoring RVO Therapy
  • Effective Strategies for Suboptimal Outcomes and Chronic Treatment in RVO
  • Q&A

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Retinal Vein Occlusion (RVO).

Target Audience
The intended audience for this educational initiative is ophthalmologists, who are clinicians responsible for the ocular evaluation and management of patients with retinal vein occlusion. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Compare current anti-VEGF therapies for RVO to select the most appropriate therapy for an individual patient.
  • Develop treatment protocols in RVO that use current therapies most effectively for a particular patient and that include appropriate follow-ups to improve outcomes in patients with RVO.
  • Modify an individualized treatment protocol for patients with RVO who are nonresponsive to first-line therapies and who require chronic treatment for macular edema.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.